Several studies showed that LRH-1 is highly upregulated in colon cancer patients and is associated with poor OS, which might suggest LRH-1 as a beneficial prognostic molecular marker for the treatment of CRC [103–105]. The gene discussed is NR5A2; the disease is colorectal carcinoma.